| Pharmaceutical active ingredients: |
| Ipodate Sodium |
| Available forms, composition and doses of Oragrafin Sodium: |
| Capsules; Oral; Ipodate Sodium 500 mg |
| Oragrafin Sodium medical category: |
| Human:Contrast mediums |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbBracco |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Onglyza | Saxagliptin Hydrochloride | Bristol-Myers Squibb; AstraZeneca; DKSH; Four Star; Zuellig Pharma |
| Ophthaine | Proparacaine Hydrochloride | Bristol-Myers Squibb; Apothecon |
| Orabase | Carmellose Sodium; Gelatin; Pectin | Bristol-Myers Squibb |
| Oracefal | Cefadroxil Monohydrate | Bristol-Myers Squibb |
| Oragrafin Calcium | Ipodate Calcium | Bristol-Myers Squibb; Bracco |
| Orahesive | Carmellose Sodium; Gelatin; Pectin | Bristol-Myers Squibb; ConvaTec |
| Ora-Testryl | Fluoxymesterone | Bristol-Myers Squibb |
| Orencia | Abatacept | Bristol-Myers Squibb; DKSH |
| Orzel | Calcium Folinate; Tegafur; Uracil | Bristol-Myers Squibb |
| Otocomb Otic | Gramicidin; Neomycin Sulfate; Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb |